Arthralgia adverse events due to immune-checkpoint inhibitors for lung cancer patients: a systematic review and meta-analysis

Arthralgia adverse events due to immune-checkpoint inhibitors for lung cancer patients: a systematic review and meta-analysis

BackgroundImmune agents targeting Programmed cell death-1 (PD-1) are a new type of cancer treatment drugs. By inhibiting the interaction between PD-1 and PD-L1, the ability of the immune system to attack tumor cells is enhanced. These immune preparations have shown significant efficacy in the treatm...

Full description

Bibliographic Details
Main Authors: Defang Zou, Xiaoping Wang, Yamin Sun, Xi Wang, Chang Lu, Aiyun Wang, Xia Wang, Yan Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
immune-checkpoint inhibitors
programmed cell death-1
lung cancer patients
systematic review
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1258287/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1258287/full

Similar Items